View Author
plasma cholesterol level study activity patient protein lipid lipoprotein transfer effect apolipoprotein apo a-iv subject apo a-i diabetes cholesteryl concentration disease serum ester lipoproteins table treatment triglycerides polymorphism atorvastatin control particle group e 3l mice phospholipid plasma pltp activity pltp activity type 2 diabetes cholesterol ef flux density metabolism result hdl cholesterol hdl-c lipase atherosclerosi apo e expression insulin phospholipid transfer protein analysis value increase triglyceride association allele hepatic netherland fraction adiponectin baseline genotype van tol liver lipid res lymph postprandial statin population difference insulin resistance variant heart ldl-c model weight relationship change factor women rlp-c density lipoproteins signi
10 Most Recent Publications
|
Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy
(Article)
Wijk, J.P.H. van Hoepelman, I.M. Koning, E.J.P. de Dallinga-Thie, G.M. Rabelink, T.J. Cabezas, M.C. |
2011-01-01
|
|
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters
(Article)
Karalis, I.K. Bergheanu, S.C. Wolterbeek, R. Dallinga-Thie, G.M. Hattori, H. Tol, A. van Liem, A.H. Jukema, J.W. |
2010-10-01
|
|
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility
(Article)
Vergeer, M. Boekholdt, S.M. Hofman, A. Uitterlinden, A.G. Duijn, C.M. van Witteman, J.C.M. Jukema, J.W. Schadt, E.E. Schoot, E. van der Kastelein, J.J. Khaw, K-T. Dullaart, R.P.F. Sandhu, M.S. Tol, A. van Trip, M.D. Dallinga-Thie, G.M. Ricketts, S.L. Wareham, N.J. Brown, M.J. Faire, U.D. Leander, K. Gigante, B. Kavousi, M. |
2010-08-03
|
|
Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism
(Article)
Haperen, R. van Samyn, H. Gent, T. van Zonneveld, A.J. Moerland, M. Grosveld, F.G. Jansen, H. Dallinga-Thie, G.M. Tol, A. van Crom, M.P.G. de |
2009-10-01
|
|
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
(Article)
Dallinga-Thie, G.M. Tol, A. van Dullaart, R.P.F. |
2009-08-01
|
|
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: Modification by triglycerides and cholesteryl ester transfer protein
(Article)
Kappelle, P.J.W.H. Zwang, L. Huisman, M.V. Banga, J.D. Sluiter, W. Dallinga-Thie, G.M. Dullaart, R.P.F. |
2009-07-01
|
|
Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia
(Article)
Koeijvoets, K.C.M.C. Mooijaart, S.P. Dallinga-Thie, G.M. Defesche, J.C. Steyerberg, E.W. Westendorp, R.G.J. Kastelein, J.J. Hagen, P.M. van Sijbrands, E.J.G. |
2009-06-24
|
|
ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia
(Article)
Koeijvoets, K.C.M.C. Net, J.B. van der Dallinga-Thie, G.M. Steyerberg, E.W. Mensink, R.P. Kastelein, J.J. Sijbrands, E.J.G. Plat, J. |
2009-06-01
|
|
Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes
(Article)
Hoek, M. van Dallinga-Thie, G.M. Steyerberg, E.W. Sijbrands, E.J.G. |
2009-04-16
|
|
Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.
(Article)
Hoek, M. van Tol, A. van Vark-van der Zee, L.C. van Jansen, H. Kastelein, J.J. Sijbrands, E.J.G. Dallinga-Thie, G.M. |
2009-01-01
|
